Publications by authors named "Shintaro Akamatsu"

Variants in mitochondrial genomes (mtDNA) can cause various neurological and mitochondrial diseases such as mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes (MELAS). Given the 16 kb length of mtDNA, continuous sequencing is feasible using long-read sequencing (LRS). Herein, we aimed to show a simple and accessible method for comprehensive mtDNA sequencing with potential diagnostic applications for mitochondrial diseases using the compact and affordable LRS flow cell "Flongle.

View Article and Find Full Text PDF
Article Synopsis
  • - Anti-IgLON5 disease is a rare autoimmune condition that can mimic symptoms of various neurodegenerative disorders, notably progressive supranuclear palsy and multiple system atrophy (MSA).
  • - In a study of 35 patients suspected of having MSA, anti-IgLON5 antibodies were found in three individuals who exhibited similar clinical features, such as parkinsonism and severe orthostatic hypotension, along with some atypical symptoms.
  • - The research suggests that anti-IgLON5 disease should be considered when diagnosing MSA, emphasizing the need for thorough physical examinations to differentiate between these conditions effectively.
View Article and Find Full Text PDF

Synopsis of recent research by authors named "Shintaro Akamatsu"

  • - Shintaro Akamatsu's recent research focuses on the diagnosis and understanding of mitochondrial diseases through targeted nanopore sequencing techniques, which are made accessible by utilizing the Flongle device for comprehensive mitochondrial DNA analysis.
  • - His work also explores the clinical characteristics of anti-IgLON5 disease, highlighting its resemblance to multiple system atrophy (MSA), thereby promoting awareness of this autoimmune condition among healthcare practitioners.
  • - Overall, Akamatsu's studies emphasize innovative diagnostic methods for complex neurological conditions and the necessity of distinguishing between similar disease presentations to ensure accurate treatment and management.